News

Hep Free NYC Awareness Event on the Steps of City Hall

Wednesday May 10, 2016 11 AM-12 PM Steps of City Hall, NYC (located in City Hall Park) Join us to commemorate May Hepatitis Awareness Month, National Hepatitis Testing Day and Hispanic Hepatitis Awareness Day. Raise awareness for testing, access and treatment! The theme this year is “Stand Up And Help End Hep” Bring posters and your organization’s banners! Invite … Continue reading Hep Free NYC Awareness Event on the Steps of City Hall

National African American Hep C Action Day – July 25 2016

July 25th is the 4th Annual National African American Hepatitis C Action Day (NAAHCAD). The National Black Leadership Commission on AIDS, Inc. invite organizations to support the day by signing-on to host activities in their City on or leading up to July 25, 2016. As a national partner, your participation will help to ensure the success and impact … Continue reading National African American Hep C Action Day – July 25 2016

Video | Everywhere But Safe: Public Injecting in New York (Sawbuck Productions)

Everywhere But Safe is a documentary film about public injection drug use in urban and rural New York. The film includes perspectives of people who inject drugs, public health professionals, and government officials. It lends a frame to create healthier communities and consider the role of Safer Injection Facilities in harm reduction, overdose prevention and control … Continue reading Video | Everywhere But Safe: Public Injecting in New York (Sawbuck Productions)

FDA approves revisions to the Olysio (simeprevir) label, including dosing recommendations

On October 5, 2015 FDA approved revisions to the Olysio (simeprevir) label to include dosing recommendations for the treatment of HCV/HIV-1 coinfection and to expand the indications and usage to include genotype 4 infection. The recommended dosage regimens and treatment duration for genotype 1 and HCV/HIV-1 co-infected patients was added to the following table: Table … Continue reading FDA approves revisions to the Olysio (simeprevir) label, including dosing recommendations

NYC Health Commissioner Wrote Letter Supporting Federal Funding for Syringe Exchange

On September 23, 2015, the NYC Health Commissioner wrote to Representative Nita Lowey in support of recent Congressional action to modify the syringe access funding rider included in the House FY 16 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill. Representative Lowey’s leadership in modifying the ban on federal funding for syringe access programs … Continue reading NYC Health Commissioner Wrote Letter Supporting Federal Funding for Syringe Exchange

Presidential Proclamation | World Hepatitis Day 2015

As President, I am committed to advancing the fight against viral hepatitis. The Affordable Care Act has increased access to quality, affordable health care. BY THE PRESIDENT OF THE UNITED STATES OF AMERICA Around the world, doctors, medical researchers, and other professionals dedicated to health care and public health are working hard every day to … Continue reading Presidential Proclamation | World Hepatitis Day 2015

FDA Approves Daklinza in Combination with Sofosbuvir for HCV Genotype 3 Infection

On July 24, 2015, FDA approved DAKLINZA (daclatasvir) a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for the treatment of chronic HCV genotype 3 infection. DAKLINZA is available as a 30 mg and 60 mg tablet. DAKLINZA is the first drug that has demonstrated safety and efficacy to treat genotype 3 … Continue reading FDA Approves Daklinza in Combination with Sofosbuvir for HCV Genotype 3 Infection

Press Release | 2015 World Hepatitis Day (Hep Free NYC)

See in PDF: World Hep Day 2015 Press Release Contact: Sue Preziotti, 917-647-1590 sue.preziotti@yahoo.com Free Screenings, Vaccinations, Health Fairs to Mark 6th Annual World Hepatitis Day in NYC (July 28) Nearly 250,000 in NYC Infected with Hepatitis B or C Viruses, which Cause 4,000 Deaths a Day Worldwide New York, NY, July 24, 2015 – The Hep Free … Continue reading Press Release | 2015 World Hepatitis Day (Hep Free NYC)

NYS Department of Health Defines HCV Experienced Provider

Source: Defining the Experienced Hepatitis C Provider, New York State Department of Health AIDS Institute, June 2015 Transformative new treatments for hepatitis C virus (HCV) will greatly expand the number of patients in New York State who can be treated successfully. This expansion promises to reduce morbidity, mortality, and the incidence of HCV transmission, but it … Continue reading NYS Department of Health Defines HCV Experienced Provider

NYC Health Dept Alert | Hep A Associated with Travel to Tulum, Mexico

As of May 2, 2015, 27 cases of hepatitis A infection have been reported among United States travelers to Tulum, Mexico. CDC has issued a Level 1 Travel Advisory recommending hepatitis A vaccination for all previously unimmunized individuals who plan to travel to Tulum, Mexico. To date, 11 cases have been reported among New York … Continue reading NYC Health Dept Alert | Hep A Associated with Travel to Tulum, Mexico

Press Conference | Hep Free NYC Awareness Event 2015

May is Hepatitis Awareness Month! National Hispanic Hepatitis Awareness Day | National Hepatitis Testing Day Join us for a citywide Hep Free NYC Awareness Event Steps of City Hall – Thursday, May 14th, 10-11AM To learn more or get involved, contact the Hep Free NYC Awareness Day Planning Group Join us on the Steps of City … Continue reading Press Conference | Hep Free NYC Awareness Event 2015

CDC | Outbreak of HIV/HCV in Prescription Med Injectors (Indiana)

This is an official CDC HEALTH ADVISORY Distributed via the CDC Health Alert Network April 24, 2015, 11:00 ET (11:00 AM ET) CDCHAN-00377 Summary The Indiana State Department of Health (ISDH) and the Centers for Disease Control and Prevention (CDC) are investigating a large outbreak of recent human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). … Continue reading CDC | Outbreak of HIV/HCV in Prescription Med Injectors (Indiana)

World Health Organization Issues 1st Hep B Treatment Guidelines

The World Health Organization (WHO) issued its first-ever guidance for the treatment of chronic hepatitis B. Worldwide, some 240 million people have chronic hepatitis B virus with the highest rates of infection in Africa and Asia. People with chronic hepatitis B infection are at increased risk of dying from cirrhosis and liver cancer. Key recommendations include: … Continue reading World Health Organization Issues 1st Hep B Treatment Guidelines

NYS DOH approves Viekira Pak as preferred drug for Hep C for FFS Medicaid beneficiaries

At the Feb 26, 2015 NYSDOH Drug Utilization Review Board meeting, the board voted to approve Viekira Pak as its preferred drug for persons chronically infected with HCV and enrolled in FFS Medicaid. Viekira Pak will be available for all chronically infected persons regardless of disease severity. This drug is also FDA approved for HIV … Continue reading NYS DOH approves Viekira Pak as preferred drug for Hep C for FFS Medicaid beneficiaries

Nominations Needed for AASLD/IAS-USA HCV Guidance Panel

Community Representative Nominations for the HCV Guidance Panel Needed The AASLD and IDSA in collaboration with IAS–USA HCV Guidance Panel is seeking an additional community representative to serve on the panel that drafts the Recommendations for Testing, Managing, and Treating Hepatitis C. Community representatives serve a 2 to 3 year term, similar to the scientific … Continue reading Nominations Needed for AASLD/IAS-USA HCV Guidance Panel

Viral Hep Coordinators are Vital. CDC AIDS.gov Blog

Dr. John Ward, Director of the Division of Viral Hepatitis at the Centers for Disease Control and Prevention, authored an article entitled “Viral Hepatitis Prevention Coordinators, a Vital CDC Program Helping to Achieve the Goals of the Viral Hepatitis Action Plan” at blog.AIDS.gov on January 9th. The Viral Hepaitits Prevention Coordinators (VHPCs) program began in … Continue reading Viral Hep Coordinators are Vital. CDC AIDS.gov Blog

Cost of Hep C Drug Means Major State Medicaid Spend

Cost of Hepatitis C drug means major state Medicaid spend. Capital. New York state’s Medicaid program spent $193.2 million during the first six months of 2014 on Sovaldi, the controversial Hepatitis C drug that carries an $84,000-per-patient price tag. In the first six months of 2014, 6,911 prescriptions were written for Sovaldi for a 12-week … Continue reading Cost of Hep C Drug Means Major State Medicaid Spend

Congratulations! Dr. Su Wang – New Board Member @ World Hep Alliance

New Regional Board Members Our Executive Board is vital to the governance of the Alliance and, crucially, to provide representation for our patient groups on a regional level. Following a largely contested election, we are happy to now announce our new Regional Board Members for 2014-2016. Our voting members have spoken and votes have been … Continue reading Congratulations! Dr. Su Wang – New Board Member @ World Hep Alliance

Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment

Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $150,360. Olysio in combination with Sovaldi is the second Hepatitis C combination treatment regimen … Continue reading Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment

AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations

AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations Check Hep C was implemented in 2012-2013 by the New York City Department of Health and Mental Hygiene (DOHMH) as a year-long demonstration project designed to increase screening, diagnosis, and linkage to care for persons chronically infected with … Continue reading AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations

BOOM!Health Promotes HCV Screening for Veterans

On Veteran’s Day, Boom!Health offered rapid HCV testing with specific outreach to veterans and baby boomers. The testing was offered at two of their locations: Harm Reduction Center, 226 East 144th St, Bronx, NY 10451 Prevention Center, 953 Southern Blvd, 2nd Floor, Bronx, NY 10459 Below is a report sent through their mailing list. Go to www.boomhealth.org and scroll to the … Continue reading BOOM!Health Promotes HCV Screening for Veterans

Harvoni: FDA Approved – Combo Pill for Hep C Treatment

Today, the FDA approved Harvoni, a fixed-dose combination pill of ledipasvir and sofosbuvir produced by Gilead Sciences, Inc. The following information was released by the FDA along with the approval. The complete product label will be available soon at DailyMed or at Drugs@FDA. Also see: FDA Press Release on the approval, and Harvoni Patient Information     On October … Continue reading Harvoni: FDA Approved – Combo Pill for Hep C Treatment

2014 NYC Hep C Research Consortium Report

The 2014 NYC HCV Research Consortium was held at The Rockefeller University on September 29, 2014. The consortium brought together providers, researchers, and community advocates to discuss the current state of hepatitis C research and practice in New York City and determine future priorities. Please review materials and presentations from the consortium below. We will … Continue reading 2014 NYC Hep C Research Consortium Report

Press Release | Project INSPIRE – CMS funded Innovations Award (NYC Health Dept)

Summary: The NYC Department of Health has announced the receipt of a new grant from the Federal government to improve treatment for hepatitis C. The grant will allow the Health Department, in conjunction with the Fund for Public Health in New York, Mount Sinai School of Medicine, Montefiore Medical Center, Weill Cornell Medical College, VNSNY Choice … Continue reading Press Release | Project INSPIRE – CMS funded Innovations Award (NYC Health Dept)

Press Release | 2014 NYC Hep B Awareness Week Press Conference

The Council of the City of New York Office of Communications City Hall New York, NY 10007 July 21, 2014 Contact: Sam Spokony [Chin]: 212-788-7259, sspokony@council.nyc.gov Jefferey LeFrancois [Johnson]: 212-564-7757, jlefrancois@council.nyc.gov Jonathan Chung [Koo]: 718-888-8747, jchung@council.nyc.gov COUNCIL MEMBERS CHIN, JOHNSON AND KOO JOIN HEALTHCARE PROVIDERS AND ADVOCATES TO LAUNCH FIRST-EVER NYC HEPATITIS B AWARENESS WEEK … Continue reading Press Release | 2014 NYC Hep B Awareness Week Press Conference

NYS Hep C Testing Bill (A9124A): In Assembly

Bill A9124A will enable New York State nurse practitioners and physicians to administer tests to determine the presence of hepatitis C in patients without a patient-specific standing order. Background: The New York City Department of Health and Mental Hygiene estimates that 146,500 individuals are living with chronic hepatitis C in NYC, and approximately half are unaware … Continue reading NYS Hep C Testing Bill (A9124A): In Assembly

Twitter Chat | CDC Q&A: National African American Hepatitis C Action Day

CDC National Prevention Information Network is hosting a Twitter chat on July 17 in preparation for National African American Hepatitis C Action Day. Please see the invitation below for details.   Please join CDC National Prevention Information Network for an upcoming Twitter chat on Thursday, July 17, 2014, from 2PM – 3PM ET. We will … Continue reading Twitter Chat | CDC Q&A: National African American Hepatitis C Action Day

NYC Commissioner of Health | Hep C Dear Colleague Letter (2014)

Newly released: NYC Dept of Health Commissioner Hep C Dear Colleague Letter NYC DOHMH COH Hep C Dear Colleague Letter 2014 (pdf)   June 2014 Dear Colleague: We are at a turning point in the fight against hepatitis C virus (HCV) infection.  Across the nation, HCV now causes more deaths annually than HIV and remains a leading … Continue reading NYC Commissioner of Health | Hep C Dear Colleague Letter (2014)

Updated! Call for Abstracts | NY Hep C Research Consortium – Sept 29

Thank you to those who have already submitted abstracts to the 2014 NYC HCV Research Consortium. Fortunately, the abstract submission window will remain open for a few more days. The updated abstract submission deadline is August 4 at 12:00 PM. Abstracts should be submitted according to the consortium guidelines for abstract submission to hsabbagh@health.nyc.gov.   Please mark your calendars … Continue reading Updated! Call for Abstracts | NY Hep C Research Consortium – Sept 29

USPSTF Recommends Hep B Screening in High Risk Individuals

The U.S. Preventative Services Task Force has updated their 2004 recommendation on hepatitis B screening and now recommends screening for hepatitis B virus (HBV) in non-pregnant adolescents and adults at high risk for infection, which may include: Those born in countries where the prevalence of HBV infection is 2% or greater Those born in the … Continue reading USPSTF Recommends Hep B Screening in High Risk Individuals

AIDS Institute Releases Hep C Testing Coverage Guide

In recognition of Hepatitis Testing Day, May 19, The AIDS Institute has released a Hepatitis C (HCV) Testing Coverage Guide to assist health care providers with navigating each of the major healthcare payers’ coverage options for preventive services, specifically for HCV screening. Additionally, the guide will help educate people on the need to get tested … Continue reading AIDS Institute Releases Hep C Testing Coverage Guide

CDC Launches “Prevention Through Health Care” Website

New Website Launched on Health System Changes On May 5, CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) launched the Prevention of HIV/AIDS, Viral Hepatitis, STDs, and TB Through Health Care Website, an online resource to help state, local, and tribal public health agencies, community-based organizations, and other partners leverage changes in the … Continue reading CDC Launches “Prevention Through Health Care” Website

Hep Free NYC Patient Navigator Network

The Hep Free NYC Patient Navigator Network is a committee of the NYC Hep B Coalition & Hep C Task Force and serves to identify and make contact with professionals who navigate patients with Hep B or C through the health care system.

NYS COH Sends Dear Colleague Letter on Hep C Testing Law

Nirav R. Shah, M.D., the Commissioner of the New York State Health Department has released a Dear Colleague letter announcing the new Hepatitis C Testing Law.  (Section 2171) The new law, which will take effect January 1st, 2014, mandates that every individual born between 1945 and 1965 be offered a Hepatitis C screening in either … Continue reading NYS COH Sends Dear Colleague Letter on Hep C Testing Law

HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Poster ID Week 2013 Conference

HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC … Continue reading HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Poster ID Week 2013 Conference

The NYC Hep C Research Consortium 2013

The NYC Hep C Research Consortium 2013 September 26th, 2013 Agenda & List of Poster Presentations: NYHCVRC_Agenda 2013 (PDF) Compendium of Abstracts: NYHCVRC Abstract Book (PDF) For more information on this event, contact: Eric Rude (erude@health.nyc.gov)

NYC Health Department Announces Strategic Plan to Combat Hepatitis C

TOP NEWS Health Department Announces Plan to Combat Hepatitis C The NYC Health Department today released the City’s first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS. In Hepatitis C in New York City: State of the Epidemic and Action … Continue reading NYC Health Department Announces Strategic Plan to Combat Hepatitis C

Sign-on Letter Urging HHS Secretary Sebelius to Add Hepatitis C Screening to Medicare

Below is a sign-on letter urging HHS Secretary Sebelius to initiate a Medicare national coverage determination process for adding hepatitis C screening to Medicare. While the USPSTF “B” grade ensures that HCV testing will not have cost-sharing for Medicare beneficiaries, the coverage determination process is necessary for adding any service. This process can take from … Continue reading Sign-on Letter Urging HHS Secretary Sebelius to Add Hepatitis C Screening to Medicare

Media Advisory | Hep Awareness Month Press Conference 2013

                                                   MEDIA ADVISORY Contact:           John Hellman Tel: 646-377-6115;  jhellman@latinoaids.org New York City Leaders and Federal Officials Call for Action to Address the Impact of Viral Hepatitis What: Elected officials, community leaders and public health officials will announce free and low cost hepatitis screenings and unveil a new PSA campaign in New York City, San … Continue reading Media Advisory | Hep Awareness Month Press Conference 2013

Coalition against Hepatitis in People of African Origin (CHIPO) NYC

Viral hepatitis is highly endemic in many parts of Africa (defined by the CDC as 8-20%), and prevalence rates among Africans living in the U.S. are similar to rates in Africa. There is a large African-born population living in the United States, specifically in New York City.  However, there is a lack of public health … Continue reading Coalition against Hepatitis in People of African Origin (CHIPO) NYC

Hep C Screening: NYC Commissioner of Health Dear Colleague Letter (April 2013)

View as PDF: Dear Colleague COH-Hep C Screening 2013 April 2013 Dear Colleague: I am writing to ask your help with diagnosing and treating hepatitis C, an increasing cause of illness and death among New Yorkers. Across the nation, hepatitis C virus (HCV) now causes more deaths annually than HIV infection[1]. Because new drug regimens … Continue reading Hep C Screening: NYC Commissioner of Health Dear Colleague Letter (April 2013)

Submit HBV Abstract | Community Health Institute Conference (Aug 23-27 in Chicago) Submission Deadline: May 3rd

The National Association of Community Health Centers would like to have more HBV research posters represented at the Community Health Institute Conference (Aug 23-27 in Chicago), therefore we are asking any health centers, networks, PCAs, researchers, academics, and others to submit online an ABSTRACT on your HBV research  by Friday May 3rd.  If selected you … Continue reading Submit HBV Abstract | Community Health Institute Conference (Aug 23-27 in Chicago) Submission Deadline: May 3rd

Team HBV NYC

With support from the NYC Hepatitis B Coalition, Team HBV NYC seeks to: Identify High School, College, and Graduate Students concerned about hepatitis B in their communities who want to take a leadership role in generating awareness and improving health outcomes in NYC. Establish a network of student leaders at educational institutions throughout NYC to … Continue reading Team HBV NYC

Request for Sites to Field Test CDC Hep C Counseling & Testing Manual

Battelle Centers for Public Health Research and Evaluation are working with the Centers for Disease Control and Prevention (CDC) to conduct a field assessment of a comprehensive counseling and testing manual for Hepatitis C (HCV).  With the expansion of HCV testing, and the introduction of the rapid HCV antibody test, Hepatitis C counseling and testing … Continue reading Request for Sites to Field Test CDC Hep C Counseling & Testing Manual

July 2012 ☼ NYC Hepatitis ABC Newsletter

view original newsletter online! July 2012  ☼ NYC Hepatitis ABC Newsletter NYC Department of Health – Office of Viral Hepatitis Coordination Upcoming Events Hep B & C Workshop & Screening for the Ghanaian Community in the Bronx. 7/6/12 and testing on 7/13/12 (2-5 pm). Location: Bronx Islamic Cultural Center: 50E Tremont Avenue, Bronx NY 10453. RSVP: Yahuza Siba, MD, African … Continue reading July 2012 ☼ NYC Hepatitis ABC Newsletter

May 2012 Hepatits ABC Newsletter

  The NYC Hepatitis ABC Newsletter is designed to provide the latest information, resources and opportunities to organizations & advocates working on viral hepatitis and related issues. View online NYC Hepatitis ABC Newsletter NYC Department of Health – Office of Viral Hepatitis Coordination   Upcoming Events Coalition Meetings  NYC Hepatitis B Coalition Meeting. May 10th (3-5 PM). … Continue reading May 2012 Hepatits ABC Newsletter

Pin It on Pinterest